Skip to Content

Join the 'Nausea / Vomiting - Radiation Induced' group to help and get support from people like you.

Nausea / Vomiting - Radiation Induced News

High-Dose Radiation May Be No Better for Low-Risk Prostate Cancer

Posted 6 Apr 2016 by Drugs.com

WEDNESDAY, April 6, 2016 – Higher doses of radiation may not benefit low-risk prostate cancer patients, a new review suggests. "In the field of radiation oncology, we often assume that the highest dose that the body can tolerate will be most effective at killing cancer," said senior study author Dr. Robert Den, a researcher at Thomas Jefferson University's cancer center in Philadelphia. "Our results argue that this may not be the case, at least not with lower-risk prostate cancer patients," Den added in a university news release. The researchers reviewed 12 studies that assessed the use of external beam radiation treatment for men with localized prostate cancer. The clinical trials included more than 6,800 patients. As patients received higher doses of radiation, there was a drop in prostate-specific antigen (PSA) levels, which are used to monitor prostate cancer. However, higher doses ... Read more

Related support groups: Prostate Cancer, Nausea/Vomiting - Radiation Induced, History - Radiation Therapy

Shorter, Intensive Radiation Works for Prostate Cancer: Study

Posted 4 Apr 2016 by Drugs.com

MONDAY, April 4, 2016 – A slightly higher dose of radiation therapy for early stage prostate cancer may reduce treatment time without compromising effectiveness, researchers report. The study included about 1,100 men with early-stage prostate cancer that had not spread beyond the gland. Half received the traditional radiation therapy program of 41 treatments over eight weeks, while the others received slightly higher doses during 28 treatments over about 5.5 weeks. After five years, cancer-free survival rates were just over 85 percent for those in the traditional group and just over 86 percent for those in the shorter treatment group, while overall survival rates were 93.2 percent and 92.5 percent, respectively. "This study has implications for public policy," said lead investigator Dr. W. Robert Lee. He is a professor at the Duke Cancer Institute's department of radiation oncology, in ... Read more

Related support groups: Prostate Cancer, Nausea/Vomiting - Radiation Induced, History - Radiation Therapy

With Early Breast Cancer, Targeted Radiation Shows Promise

Posted 9 Mar 2016 by Drugs.com

WEDNESDAY, March 9, 2016 – For women with early stage breast cancer, targeted doses of radiation therapy may be as effective as standard radiation treatment of the entire breast, a new British study suggests. The research only tracked women for five years, so it isn't definitive. Still, "this contributes to a growing body of evidence that a large proportion of women over 50 years old with small breast cancers can avoid whole breast radiotherapy," said study co-author Dr. John Yarnold. He is a professor of clinical oncology with the Institute of Cancer Research in London. At issue: What is the best treatment for low-risk early breast cancer? Many studies have shown that surgery to remove the cancerous lump – but not the entire breast – followed by radiation of the whole breast reduces the chance of breast cancer returning, said Dr. Reshma Jagsi, who was not involved with the new ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer, Prevention, Breast Cancer - Palliative, Nausea/Vomiting - Radiation Induced, History - Radiation Therapy, Radiation Injury of Bone

Radiation Therapy for Prostate Cancer May Carry Certain Risks

Posted 3 Mar 2016 by Drugs.com

THURSDAY, March 3, 2016 – Radiation treatment for prostate cancer may put men at a slight increased risk for other cancers, a new review suggests. The analysis of 21 studies revealed that prostate cancer patients who had radiation therapy had a slightly increased risk of bladder, colon and rectal cancers, compared to those who did not receive radiation or had surgery. However, the rates of these secondary cancers were low, particularly when compared to rates of other complications – such as urinary incontinence and erectile dysfunction – associated with prostate cancer treatment, the researchers added. And the study did not prove that radiation treatment caused secondary cancers. Also, there was no increased risk of lung or blood cancers among those in the radiation group, according to the study published March 2 in the BMJ. Further research is needed to confirm these findings, but ... Read more

Related support groups: Prostate Cancer, Nausea/Vomiting - Radiation Induced, History - Radiation Therapy

Cancer Patients Who Miss Radiation Treatments at High Risk for Relapse

Posted 15 Feb 2016 by Drugs.com

MONDAY, Feb. 15, 2016 – Cancer patients who miss two or more radiation treatment sessions are at increased risk for a return of their cancer, a new study finds. The study included more than 1,200 patients who had radiation therapy for head and neck, breast, lung, cervical, uterine or rectal cancer between 2007 and 2012. Of those patients, 22 percent missed two or more scheduled radiation treatment appointments. While all patients eventually completed their radiation therapy regimens, they were prolonged an average of one week for those who missed two or more treatment sessions. Rates of cancer recurrence were 16 percent for patients who missed two or more radiation sessions and 7 percent for those who did not, according to the study published online recently in the International Journal of Radiation Oncology Biology Physics. "This study shows that the health of our patients can improve ... Read more

Related support groups: Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, Head and Neck Cancer, Nausea/Vomiting - Radiation Induced, History - Radiation Therapy, Urinary Tract Cancer

'Suicide Gene Therapy' Plus Radiation Fights Prostate Cancer: Study

Posted 14 Dec 2015 by Drugs.com

MONDAY, Dec. 14, 2015 – A combination of "suicide gene therapy" and radiation is highly effective in treating prostate cancer, researchers say. In this type of gene therapy, a patient's cancer cells are genetically modified so that they prompt the person's immune system to attack the cells, the Houston Methodist Hospital researchers explained. "We have created a vaccine with the patient's own cancer cells, a treatment that complements, and may even enhance, what we can achieve with traditional radiation and hormonal therapies," study senior author Dr. E. Brian Butler, chair of the department of radiation oncology, said in a hospital news release. The study included 62 patients who were divided into two groups. One group, who had cancer cells confined to the prostate, received radiation treatment. The second group, who had more aggressive prostate cancer, received both radiation and ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH), Prostate Cancer, Prostatitis, Nausea/Vomiting - Radiation Induced, History - Radiation Therapy, Genitourinary Surgical and Other Conditions, Prostate Tumor - Benign

Lumpectomy Plus Radiation May Beat Mastectomy for Early Breast Cancer

Posted 10 Dec 2015 by Drugs.com

THURSDAY, Dec. 10, 2015 – Women with early stage breast cancer may survive longer if they opt for the less-extensive surgery called lumpectomy, followed by radiation, rather than a mastectomy, a new study suggests. "I think these results offer women important information to discuss with their doctors when making a treatment decision for early stage breast cancer," said lead researcher Sabine Seisling, of the Netherlands Comprehensive Cancer Organization, in Utrecht. Mastectomy removes the entire the breast, while lumpectomy involves removing only the tumor with some surrounding tissue. Some studies have suggested that women with early stage breast cancer have a better five-year survival rate after lumpectomy. The new study, which included 37,000 Dutch women, found that the advantage may also extend to the longer term. Of nearly 22,000 patients who underwent lumpectomy plus radiation, ... Read more

Related support groups: Surgery, Cancer, Provera, Depo-Provera, Breast Cancer, Lupron, Tamoxifen, Medroxyprogesterone, Arimidex, Femara, Lupron Depot, Anastrozole, Zoladex, Evista, Megestrol, Letrozole, Megace, Aromasin, Breast Cancer - Adjuvant, Casodex

They Overcame Childhood Cancer, But Now Obesity?

Posted 11 May 2015 by Drugs.com

MONDAY, May 11, 2015 – Certain treatments may increase a childhood cancer survivor's risk of obesity later in life, a new study says. "The ability to identify patients at increased risk may guide selection of therapeutic protocols that will maximize treatment outcomes while simultaneously minimizing the risk of long-term complications among children diagnosed with cancer," said study co-leader Kirsten Ness, of St. Jude Children's Research Hospital in Memphis. The researchers looked at nearly 2,000 people who'd been diagnosed with childhood cancer at least 10 years earlier. They found that almost half who underwent cranial radiation were obese. This compared with just over 29 percent of those who did not receive that type of treatment. Cranial radiation is used to prevent or delay the spread of cancer to the brain. The risk of obesity among survivors treated with cranial radiation was ... Read more

Related support groups: Obesity, Cancer, Prednisone, Methylprednisolone, Prednisolone, Hydrocortisone, Medrol, Cortisone, Dexamethasone, Triamcinolone, Betamethasone, Budesonide, Decadron, Entocort, Solu-Medrol, Entocort EC, Cortef, Medrol Dosepak, Celestone, Orapred

FDA Approves Strativa Pharmaceuticals' Zuplenz (ondansetron) Oral Soluble Film

Posted 7 Jul 2010 by Drugs.com

WOODCLIFF LAKE, N.J., July 2 /PRNewswire/ – Strativa Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved Zuplenz (ondansetron) oral soluble film for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and radiotherapy-induced nausea and vomiting. Zuplenz, a unique formulation of ondansetron, is the first oral soluble film approved by the FDA as a prescription medication. The FDA approval was granted based on clinical study data comparing the bioequivalence of Zuplenz 8 mg to Zofran ODT (orally dissolving tablet) 8 mg. The pharmacokinetic results of these studies demonstrated that a single dose of Zuplenz, taken with or without water and under fed and fasting conditions, was comparable to Zofran ODT. "The FDA approval of Zuplenz marks an important milestone for Strativa as it reinforces our commitment ... Read more

Related support groups: Ondansetron, Nausea/Vomiting - Chemotherapy Induced, Nausea/Vomiting - Postoperative, Nausea/Vomiting - Radiation Induced

Ask a Question

Further Information

Related Condition Support Groups

Nausea / Vomiting

Related Drug Support Groups

Zofran, ondansetron, Zofran ODT, Kytril, Zuplenz, Granisol, granisetron